D-index as a marker of bloodstream infections in patients with allogeneic hematopoietic stem cell transplantation
- PMID: 33590904
- PMCID: PMC8364926
- DOI: 10.1111/tid.13588
D-index as a marker of bloodstream infections in patients with allogeneic hematopoietic stem cell transplantation
Abstract
Background: Neutropenia is a risk factor for development of infections; however, the direct effect of neutropenia on development of bloodstream infection (BSI) is not known. D-index, which is area between the neutrophil time curve and a neutrophil count of 0.5 × 109 /L, incorporates the combined effect of severity and duration of neutropenia. We aimed to evaluate whether D-index can be used as a marker for BSI in patients with allogeneic stem cell transplantation.
Method: We conducted a retrospective cohort study of patients undergoing allogeneic stem cell transplantation between January 1, 2005, and September 30, 2015. The primary outcome measure was the development of BSI within 30 days of transplantation.
Results: A total of 714 patients were included in the study of whom 101 developed BSI. Patients with BSI had a significantly higher median D-index value compared with patients who did not have BSI (4990 vs. 3570, P < .001). As a marker, the performance of the D-index was similar to that of the duration of profound neutropenia (P = .18) and significantly better than the total duration of neutropenia (P = .001).
Conclusion: The D-index performed better than the total duration of neutropenia as a marker for BSI in patients with allogeneic stem cell transplantation. There was no difference between D-index and, a more easily calculable indicator, duration of profound neutropenia.
Keywords: D-index; allogeneic hematopoietic stem cell transplantation; bacteremia; bloodstream infection; neutropenia.
© 2021 Wiley Periodicals LLC.
Conflict of interest statement
Figures




Similar articles
-
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.Transpl Infect Dis. 2014 Feb;16(1):106-14. doi: 10.1111/tid.12175. Epub 2013 Dec 30. Transpl Infect Dis. 2014. PMID: 24372809
-
Retrospective evaluation of the area over the neutrophil curve index to predict early infection in hematopoietic stem cell transplantation recipients.Biol Blood Marrow Transplant. 2010 Oct;16(10):1355-61. doi: 10.1016/j.bbmt.2010.04.012. Epub 2010 May 10. Biol Blood Marrow Transplant. 2010. PMID: 20457267
-
Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation.Expert Rev Anti Infect Ther. 2023 Jan;21(1):87-90. doi: 10.1080/14787210.2023.2151440. Epub 2022 Nov 28. Expert Rev Anti Infect Ther. 2023. PMID: 36416178
-
Epidemiology of bloodstream infections and the impact of antimicrobial resistance in pediatric hematopoietic cell transplant.Transpl Infect Dis. 2024 Feb;26(1):e14228. doi: 10.1111/tid.14228. Epub 2024 Jan 5. Transpl Infect Dis. 2024. PMID: 38180287 Review.
-
Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.Bone Marrow Transplant. 1999 Feb;23(3):271-5. doi: 10.1038/sj.bmt.1701562. Bone Marrow Transplant. 1999. PMID: 10084259 Review.
References
-
- Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 2006;106(10):2258–2266. - PubMed
-
- Bodey GP, Buckley M, SATHE Y, FREIREICH EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Annals of internal medicine. 1966;64(2):328–340. - PubMed
-
- van der Velden WJ, Herbers AH, Netea MG, Blijlevens NM. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol. 2014;167(4):441–452. - PubMed
-
- Freifeld AG, Bow EJ, Sepkowitz KA, et al.Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52(4):e56–93. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials